Objective
to report the effect of i.v. beta-blockers administration before PCI on the adverse event rate at 1 year in patients with STEMI
Study
double-blind placebo controlled randomised trial
Population
patients with STEMI undergoing PPCI
Endpoints
composite death, non-fatal MI or revascularisation
Conclusion
i.v. metoprolol administration early before PPCI for STEMI does not reduce clinical adverse events at 1 year
Roolvink et al. EuroIntervention 2018;14:688-91
